» Articles » PMID: 25079103

Management of Prostate Cancer in Older Patients: Updated Recommendations of a Working Group of the International Society of Geriatric Oncology

Abstract

In 2010, the International Society of Geriatric Oncology (SIOG) developed treatment guidelines for men with prostate cancer who are older than 70 years old. In 2013, a new multidisciplinary SIOG working group was formed to update these recommendations. The consensus of the task force is that older men with prostate cancer should be managed according to their individual health status, not according to age. On the basis of a validated rapid health status screening instrument and simple assessment, the task force recommends that patients are classed into three groups for treatment: healthy or fit patients who should have the same treatment options as younger patients; vulnerable patients with reversible impairment who should receive standard treatment after medical intervention; and frail patients with non-reversible impairment who should receive adapted treatment.

Citing Articles

Age-dependent differences in breast tumor microenvironment: challenges and opportunities for efficacy studies in preclinical models.

Falvo P, Gruener S, Orecchioni S, Pisati F, Talarico G, Mitola G Cell Death Differ. 2025; .

PMID: 39870804 DOI: 10.1038/s41418-025-01447-1.


Dynamics in the Prostate Immune Microenvironment Induced by Androgen Deprivation Therapy.

Yanai Y, Kosaka T, Mikami S, Arai M, Watanabe K, Takeda T Prostate. 2024; 85(3):308-314.

PMID: 39580660 PMC: 11720370. DOI: 10.1002/pros.24828.


Assessment of geriatric and clinical domains for development and validation of a novel nomogram to predict the prognosis of older patients with breast cancer: a real-world retrospective cohort study.

Lin Y, Song Y, Xu Y, Wang C, Xu Y, Huang X Front Oncol. 2023; 13:1250927.

PMID: 38090492 PMC: 10715059. DOI: 10.3389/fonc.2023.1250927.


Comprehensive geriatric assessment predicts radiation-induced acute toxicity in prostate cancer patients.

Paal K, Stranz B, Thurner E, Langsenlehner U, Renner W, Brunner T Strahlenther Onkol. 2023; 200(3):208-218.

PMID: 37658924 PMC: 10876759. DOI: 10.1007/s00066-023-02132-3.


Item analysis of G8 screening in uro-oncologic geriatric patients.

Bouzan J, Nellas S, Stoilkov B, Willschrei P, Horstmann M Int Urol Nephrol. 2023; 55(6):1441-1446.

PMID: 37067702 PMC: 10185629. DOI: 10.1007/s11255-023-03594-1.